Menu

Blog

Archive for the ‘biotech/medical’ category: Page 812

Oct 23, 2022

Eating Omega-3 Fatty Acids in Midlife May Sharpen Thinking Skills and Improve Brain Structure

Posted by in categories: biotech/medical, health, neuroscience

People who eat more foods with omega-3 fatty acids in midlife may have superior thinking skills and even better brain structure than people who eat few foods containing the fatty acids. This is according to an exploratory study that was recently published in Neurology, the medical journal of the American Academy of Neurology. Omega-3 fatty acids are found in fish such as salmon, sardines, lake trout, and albacore tuna. They are also found in dietary supplements as well as foods that are fortified with the fatty acids.

“If people could improve their cognitive resilience and potentially ward off dementia with some simple changes to their diet, that could have a large impact on public health.” —

“Improving our diet is one way to promote our brain health,” said study author Claudia L. Satizabal, PhD, of the University of Texas Health Science Center at San Antonio. “If people could improve their cognitive resilience and potentially ward off dementia with some simple changes to their diet, that could have a large impact on public health. Even better, our study suggests that even modest consumption of omega-3 may be enough to preserve brain function. This is in line with the current American Heart Association dietary guidelines to consume at least two servings of fish per week to improve cardiovascular health.”

Oct 23, 2022

Genes link bipolar, schizophrenia, once thought unrelated

Posted by in categories: biotech/medical, neuroscience

ELIZABETHTOWN, Ky. (AP) — When Chastity Murry had her first psychotic break, she went into her bathroom and downed a whole bottle of pills, hoping to die. Her teenage daughter had to perform CPR to save her life.

Around that same time more than a decade ago, the man who would become her husband, Dante Murry, also lost touch with reality and considered suicide.

Different illnesses led them down similar paths – bipolar disorder in her case and schizoaffective disorder in his – conditions long considered by many to be distinct and unrelated.

Oct 23, 2022

Breaths Per Minute While Asleep: What’s Optimal?

Posted by in categories: biotech/medical, genetics

Join us on Patreon!
https://www.patreon.com/MichaelLustgartenPhD

Bristle Discount Link (Oral microbiome quantification):
ConquerAging15
https://www.bmq30trk.com/4FL3LK/GTSC3/

Continue reading “Breaths Per Minute While Asleep: What’s Optimal?” »

Oct 23, 2022

Wireless implant could help remove deadly brain tumors

Posted by in categories: biotech/medical, nanotechnology, neuroscience

Brain tumors are among the most deadly and difficult-to-treat cancers. Glioblastoma, a particularly aggressive form, kills more than 10,000 Americans a year and has a median survival time of less than 15 months.

For patients with brain tumors, treatment typically includes open-skull surgery to remove as much of the tumor as possible followed by chemotherapy or radiation, which come with serious side effects and numerous hospital visits.

What if a patient’s brain tumor could be treated painlessly, without anesthesia, in the comfort of their home? Researchers at Stanford Medicine have developed, and tested in mice, a small wireless device that one day could do just that. The device is a remotely activated implant that can heat up nanoparticles injected into the tumor, gradually killing cancerous cells.

Oct 23, 2022

UT Austin scientists design safer Cas9 with improved CRISPR gene editing accuracy

Posted by in categories: bioengineering, biotech/medical, genetics

The CRISPR system, which involves a Cas enzyme to cut DNA, is a powerful tool for gene editing. But the genetic scissors sometimes make changes at the wrong place, creating a major safety problem that could limit their therapeutic use.

Now, scientists at the University of Texas (UT) at Austin have refined the Cas9 protein used in the Nobel Prize-winning CRISPR-Cas9 tool. The new version, dubbed SuperFi-Cas9, was thousands of times less likely to perform off-target editing but just as efficient at on-target editing as the original version, the team said in a paper published in Nature.

“This really could be a game-changer in terms of a wider application of the CRISPR-Cas systems in gene editing,” Kenneth Johnson, Ph.D., the study’s co-senior author, said in a statement.

Oct 22, 2022

Particle Physics Pushing Cancer Treatment Boundaries

Posted by in category: biotech/medical

Researchers at Europe’s science lab CERN, who regularly use particle physics to challenge our understanding of the universe, are also applying their craft to upend the limits to cancer treatment.

The physicists here are working with giant particle accelerators in search of ways to expand the reach of cancer radiation therapy, and take on hard-to-reach tumours that would otherwise have been fatal.

In one CERN lab, called CLEAR, facility coordinator Roberto Corsini stands next to a large, linear particle accelerator consisting of a 40-metre metal beam with tubes packed in aluminium foil at one end, and a vast array of measurement instruments and protruding colourful wires and cables.

Oct 22, 2022

Insect-eating mushroom could produce new antiviral and cancer drugs

Posted by in categories: biotech/medical, food

In a new study, researchers grew cordyceps mushrooms on six different kinds of insects. They found that mushrooms grown amid high levels of oleic fatty acid contained the most cordycepin, a potential therapeutic agent with antiviral and anticancer properties.

Oct 22, 2022

A new robot can help with the fear of injections during medical treatments

Posted by in categories: biotech/medical, robotics/AI, wearables

The wearable robot helps patients who are afraid of needles.

A recent study in Japan has revealed that a hand-held soft robot can improve the experience of patients while undergoing medical treatments, such as injections and other unpleasant therapies or immunizations.


Inspired by vaccinations during Covid

Continue reading “A new robot can help with the fear of injections during medical treatments” »

Oct 22, 2022

Radioactive implant wipes tumors in unprecedented pre-clinical success

Posted by in categories: biotech/medical, materials

Engineers at Duke University have developed a novel delivery system for cancer treatment and demonstrated its potential against one of the disease’s most troublesome forms. In newly published research in mice with pancreatic cancer, the scientists showed how a radioactive implant could completely eliminate tumors in the majority of the rodents, demonstrating what they say is the most effective treatment ever studied in these pre-clinical models.

Pancreatic cancer is notoriously difficult to diagnose and treat, with tumor cells of this type highly evasive and loaded with mutations that make them resistant to many drugs. It accounts for just 3.2 percent of all cancers, yet is the third leading cause of cancer-related death. One way of tackling it is by deploying chemotherapy to hold the tumor cells in a state that makes them vulnerable to radiation, and then hitting the tumor with a targeted radiation beam.

But doing so in a way that attacks the tumor but doesn’t expose the patient to heavy doses of radiation is a fine line to tread, and raises the risk of severe side effects. Another method scientists are exploring is the use of implants that can be placed directly inside the tumor to attack it with radioactive materials from within. They have made some inroads using titanium shells to encase the radioactive samples, but these can cause damage to the surrounding tissue.

Oct 22, 2022

New Protein Identified That May Contribute to Alzheimer’s Disease

Posted by in categories: biotech/medical, life extension, neuroscience

Alzheimer’s disease (AD) is a debilitating progressive illness that begins with mild memory loss and slowly destroys cognitive function and memory. It currently has no cure and is predicted to affect over 100 million people worldwide by 2050. In the United States, AD is the leading cause of dementia in older adults and the 7th most common cause of death, according to the National Institute on Aging.

Ongoing Alzheimer’s research is focused on two key neurotoxic proteins: amyloid beta (Aβ) and tau. Although these proteins have been shown to be associated with AD, the levels of Aβ and tau do not consistently explain or correlate with the severity of cognitive decline for some people with the disease.

Investigators at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, set out to identify other proteins that may be directly involved with fundamental aspects of AD, like synaptic loss and neurodegeneration. They exposed laboratory neurons to human brain extracts from about 40 people who either had AD, were protected from AD despite having high Aβ and tau levels, or were protected from AD with little or no Aβ and tau in their brains.

Page 812 of 2,681First809810811812813814815816Last